KR100585442B1 - 암로디핀 벤젠설포네이트의 제조 방법 - Google Patents
암로디핀 벤젠설포네이트의 제조 방법 Download PDFInfo
- Publication number
- KR100585442B1 KR100585442B1 KR1020027000052A KR20027000052A KR100585442B1 KR 100585442 B1 KR100585442 B1 KR 100585442B1 KR 1020027000052 A KR1020027000052 A KR 1020027000052A KR 20027000052 A KR20027000052 A KR 20027000052A KR 100585442 B1 KR100585442 B1 KR 100585442B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- methyl
- amlodipine
- quaternary ammonium
- alkali metal
- Prior art date
Links
- 0 C*C1=C(*O*)*C(C)=C(*)C1c1ccccc1C Chemical compound C*C1=C(*O*)*C(C)=C(*)C1c1ccccc1C 0.000 description 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
Claims (12)
- 제 1 항에 있어서, X가 제 1 항에 정의된 바와 같은 화학식 II의 프탈아미드산 유도체를 화학량론적 양 이상의 벤젠설폰산과 반응시킴을 특징으로 하는 방법.
- 제 1 항 또는 제 2 항에 있어서, 반응을 70 내지 80 ℃ 온도에서 수행함을 특징으로 하는 방법.
- 삭제
- 삭제
- 2-[2-N-(2-카복시벤조일)-아미노에톡시메틸]-4-(2-클로로페닐)-3-에톡시카보닐-5-메톡시카보닐-6-메틸-1,4-디하이드로피리딘.
- 4-(2-클로로페닐)-3-에톡시카보닐-5-메톡시카보닐-6-메틸-2-(2-프탈이미도에톡시)메틸-1,4-디하이드로피리딘을 알칼리 금속 수산화물, 알칼리 토 금속 산화물 또는 수산화물, 및 4급 암모늄 중에서 선택된 강 염기와 반응시키고, 경우에 따라, 수득된 화학식 II(여기에서 X는 알칼리 금속 또는 알칼리 토 금속 또는 4급 암모늄을 나타낸다)의 화합물을 단리하거나 단리시키지 않고 무기 산과 반응시킴을 특징으로 하는, 신규의 화학식 II(이때 X는 수소 또는 알칼리 금속 또는 알칼리 토 금속 또는 4급 암모늄을 나타낸다)의 프탈아미드산 유도체의 제조 방법.화학식 II
- 삭제
- 제 8 항에 있어서, 강 염기를 화학량론적 양을 사용하며, 경우에 따라 상기 염기를 화학량론적 양의 무기 산으로 중화시킴을 특징으로 하는 방법.
- 제 8 항 또는 제 10 항에 있어서, 강 염기와의 반응을 실온에서 수행하고, 무기 산과의 반응은 빙-냉 중에 수행함을 특징으로 하는 방법.
- 제 8 항에 있어서, 암로디핀 벤젠설포네이트의 제조에 사용됨을 특징으로 하는 방법.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/HU1999/000050 WO2001002360A1 (en) | 1999-07-05 | 1999-07-05 | Process for preparing amlodipine benzenesulphonate |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020022760A KR20020022760A (ko) | 2002-03-27 |
KR100585442B1 true KR100585442B1 (ko) | 2006-06-02 |
Family
ID=10991279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020027000052A KR100585442B1 (ko) | 1999-07-05 | 1999-07-05 | 암로디핀 벤젠설포네이트의 제조 방법 |
Country Status (24)
Country | Link |
---|---|
US (1) | US6596874B1 (ko) |
EP (1) | EP1196383B1 (ko) |
JP (1) | JP3764386B2 (ko) |
KR (1) | KR100585442B1 (ko) |
CN (1) | CN1141297C (ko) |
AT (1) | ATE283841T1 (ko) |
AU (1) | AU777565B2 (ko) |
BG (1) | BG65657B1 (ko) |
CA (1) | CA2376540C (ko) |
CZ (1) | CZ300509B6 (ko) |
DE (1) | DE69922417T2 (ko) |
DK (1) | DK1196383T3 (ko) |
EA (1) | EA004208B1 (ko) |
EE (1) | EE05398B1 (ko) |
ES (1) | ES2234272T3 (ko) |
HK (1) | HK1044151B (ko) |
MX (1) | MXPA01013407A (ko) |
NO (1) | NO321714B1 (ko) |
NZ (1) | NZ517013A (ko) |
PL (1) | PL194193B1 (ko) |
PT (1) | PT1196383E (ko) |
SK (1) | SK285611B6 (ko) |
UA (1) | UA72768C2 (ko) |
WO (1) | WO2001002360A1 (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100354806B1 (ko) * | 2000-06-21 | 2002-10-05 | 한국유나이티드제약 주식회사 | 암로디핀 베실레이트의 신규 중간체 및 그의 제조방법 |
ATE454890T1 (de) | 2001-07-06 | 2010-01-15 | Lek Pharmaceuticals | Verfahren zur herstellung hochreines amlodipinbenzolsulfonat |
US6680334B2 (en) | 2001-08-28 | 2004-01-20 | Pfizer Inc | Crystalline material |
AR037565A1 (es) * | 2001-11-21 | 2004-11-17 | Synthon Bv | Formas de sales de amlodipina y procedimientos para prepararlas. |
KR100496436B1 (ko) * | 2002-07-30 | 2005-06-20 | 씨제이 주식회사 | 암로디핀의 유기산염 |
KR100462304B1 (ko) * | 2002-07-30 | 2004-12-17 | 씨제이 주식회사 | 암로디핀의 유기산염 |
KR100467669B1 (ko) * | 2002-08-21 | 2005-01-24 | 씨제이 주식회사 | 암로디핀의 유기산염 |
US6784297B2 (en) | 2002-09-04 | 2004-08-31 | Kopran Limited | Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate |
JP2008013489A (ja) * | 2006-07-06 | 2008-01-24 | Ohara Yakuhin Kogyo Kk | ベシル酸アムロジピン含有錠剤 |
EP1975167A1 (en) | 2007-03-30 | 2008-10-01 | Esteve Quimica, S.A. | Acetone solvate of phthaloyl amlodipine |
CN101812014B (zh) * | 2010-04-28 | 2011-08-24 | 王明 | 一种苯磺酸氨氯地平化合物及其制法 |
CN102993083A (zh) * | 2012-12-21 | 2013-03-27 | 王学军 | 一种苯磺酸氨氯地平的制备方法 |
CN104262237A (zh) * | 2014-09-28 | 2015-01-07 | 常州瑞明药业有限公司 | 氨氯地平自由碱的合成方法 |
US11452690B1 (en) | 2021-01-27 | 2022-09-27 | ECI Pharmaceuticals, LLC | Oral liquid compositions comprising amlodipine besylate and methods of using the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK161312C (da) * | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
GB8608335D0 (en) | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
SI9200344B (sl) * | 1992-11-26 | 1998-06-30 | Lek, | Postopek za pripravo amlodipin benzensulfonata |
HU221810B1 (hu) * | 1997-08-12 | 2003-01-28 | EGIS Gyógyszergyár Rt. | Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei |
DE19738943B4 (de) | 1997-09-05 | 2008-01-03 | Siemens Ag | Verfahren und Einrichtung zur Bestimmung von Eigenschaften eines Stahls |
-
1999
- 1999-05-07 UA UA2002020897A patent/UA72768C2/uk unknown
- 1999-07-05 CN CNB998167746A patent/CN1141297C/zh not_active Expired - Lifetime
- 1999-07-05 WO PCT/HU1999/000050 patent/WO2001002360A1/en active IP Right Grant
- 1999-07-05 DK DK99933061T patent/DK1196383T3/da active
- 1999-07-05 CZ CZ20014690A patent/CZ300509B6/cs unknown
- 1999-07-05 PT PT99933061T patent/PT1196383E/pt unknown
- 1999-07-05 EP EP99933061A patent/EP1196383B1/en not_active Expired - Lifetime
- 1999-07-05 JP JP2001507800A patent/JP3764386B2/ja not_active Expired - Lifetime
- 1999-07-05 ES ES99933061T patent/ES2234272T3/es not_active Expired - Lifetime
- 1999-07-05 PL PL99352493A patent/PL194193B1/pl unknown
- 1999-07-05 US US10/019,424 patent/US6596874B1/en not_active Expired - Lifetime
- 1999-07-05 AU AU49237/99A patent/AU777565B2/en not_active Expired
- 1999-07-05 EE EEP200100686A patent/EE05398B1/xx unknown
- 1999-07-05 KR KR1020027000052A patent/KR100585442B1/ko not_active IP Right Cessation
- 1999-07-05 MX MXPA01013407A patent/MXPA01013407A/es not_active IP Right Cessation
- 1999-07-05 DE DE69922417T patent/DE69922417T2/de not_active Expired - Lifetime
- 1999-07-05 SK SK2-2002A patent/SK285611B6/sk not_active IP Right Cessation
- 1999-07-05 EA EA200200125A patent/EA004208B1/ru not_active IP Right Cessation
- 1999-07-05 CA CA002376540A patent/CA2376540C/en not_active Expired - Lifetime
- 1999-07-05 AT AT99933061T patent/ATE283841T1/de active
- 1999-07-05 NZ NZ517013A patent/NZ517013A/en not_active IP Right Cessation
-
2001
- 2001-12-03 BG BG106164A patent/BG65657B1/bg unknown
-
2002
- 2002-01-04 NO NO20020029A patent/NO321714B1/no not_active IP Right Cessation
- 2002-08-06 HK HK02105733.9A patent/HK1044151B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100585442B1 (ko) | 암로디핀 벤젠설포네이트의 제조 방법 | |
EP2010498B1 (en) | Synthesis of acylaminoalkenylene amides useful as substance p antagonists | |
US4721723A (en) | Anti-depressant crystalline paroxetine hydrochloride hemihydrate | |
US5354760A (en) | Crystalline Tiagabine monohydrate, its preparation and use | |
JP2002528436A (ja) | アムロジピン合成用中間体、その調製方法および使用方法 | |
EP1674463A1 (en) | Rabeprazole sodium salt in crystalline hydrate form | |
EP0599220B1 (en) | A process for the preparation of amlodipine benzenesulphonate | |
SK288022B6 (sk) | Process for preparing tropenol | |
US6031114A (en) | Process for pyrrolidinyl hydroxamic acid compounds | |
WO2005023769A1 (en) | Process for the preparation of amlodipine salts | |
KR100469030B1 (ko) | 시사프라이드의 합성방법 | |
HU202474B (en) | Process for producing methyl 3-aminocrotonate | |
US7153970B2 (en) | High purity amlodipine benzenesulfonate and a process for its preparation | |
JPH0881427A (ja) | [[4−置換アセチル−o−フェニレン]ジオキシ]ジ酢酸誘導体及びその製造方法 | |
JPH01246251A (ja) | フエニルエーテル誘導体 | |
SI21067A2 (sl) | Amlodipin hemimaleat | |
WO2007131759A1 (en) | A process for the preparation of amlodipine benzenesulfonate | |
JPH0257541B2 (ko) | ||
MXPA01004128A (en) | Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130516 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140515 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150514 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160512 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170511 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180510 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190516 Year of fee payment: 14 |
|
EXPY | Expiration of term |